Biotech

All Articles

2 cancer biotechs combine, developing international impact

.OncoC4 is taking AcroImmune-- and also its own internal clinical manufacturing capabilities-- under...

Amgen records very first stage 3 gain for $400M dermatitis drug

.Amgen has shared (PDF) the very first phase 3 data on its own $400 million eczema medicine, connect...

Biogen, UCB report phase 3 lupus succeed after failing earlier trial

.Biogen and also UCB's bet one's bottom dollar developing right into phase 3 on the back of an unsuc...

Aptadir really hopes brand-new RNA preventions may turn around challenging cancers

.Italian biotech Aptadir Therapeutics has released along with the guarantee that its pipeline of pre...

Wave surfs DMD results to regulators' doors, delivering stock up

.Wave Lifestyle Sciences has met its own objective in a Duchenne muscular dystrophy (DMD) study, pla...

Sanofi tweezes new CSO coming from in-stealth biotech

.After a few years in biotech, Mike Quigley, Ph.D., is going back to the pharma layer, occupying the...

Achilles drops tissue therapy system, supports for cutbacks after skipping 'office feasibility' targets

.Achilles Therapeutics has destroyed its tactic. The English biotech is knocking off on its own clin...

Aligos heralds phase 2 MASH win, slashing liver body fat as much as 46%

.Aligos Therapeutics is heralding a midstage succeed in metabolic-dysfunction associated steatohepat...

Basilea scores $268M BARDA backing for antifungals, prescription antibiotics

.Basilea Pharmaceutica's job cultivating brand new antifungals has received a notable improvement fr...

Capricor markets Europe rights to late-stage DMD therapy for $35M

.Possessing already scooped up the united state civil rights to Capricor Therapeutics' late-stage Du...